Depression, Bipolar
44
11
12
21
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
2.3%
1 terminated out of 44 trials
95.5%
+9.0% vs benchmark
34%
15 trials in Phase 3/4
43%
9 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (44)
Natural History of Depression, Bipolar Disorder and Suicide Risk
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)
Right-sided 1-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) Versus Left-sided Intermittent Theta Burst Stimulation (iTBS) in Patients With Depression
Pramipexole to Target "Anhedonic Depression"
Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
Mental Health Mission Mood Disorder Cohort Study
Digital Phenotypes for Predicting Depression
Transcranial Direct Current Stimulation Therapy for Bipolar Depression
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
Optimal Electrical Stimulus During Electroconvulsive Therapy
IM Ketamine vs Midazolam for Suicidal ER Patients
Dallas 2K: A Natural History Study of Depression
BioClock: Bright Light Therapy for Depressive Disorders
Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression
A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression
LIVES: Personalized Lifestyle Intervention for Patients With Depression
Study of the Effectiveness of Vestibular Stimulation Treatment in the Depressive Phase of Bipolar Disorder
Study of a Vestibular Biomarker of Phase in Bipolar Disorder
Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes